Omron (OTCMKTS:OMRNY) Rating Increased to Hold at Zacks Research

Omron (OTCMKTS:OMRNY) was upgraded by equities research analysts at Zacks Research from a “strong sell” rating to a “hold” rating in a research report issued on Monday,Zacks.com reports.

Separately, Jefferies Financial Group downgraded shares of Omron from a “buy” rating to a “hold” rating in a report on Tuesday, June 16th. Two equities research analysts have rated the stock with a Hold rating, Based on data from MarketBeat.com, Omron currently has an average rating of “Hold”.

Omron Stock Up 0.7%

OMRNY opened at $43.24 on Monday. The company has a debt-to-equity ratio of 0.08, a quick ratio of 1.41 and a current ratio of 1.83. The company has a market capitalization of $8.50 billion, a PE ratio of 41.18, a P/E/G ratio of 0.63 and a beta of 1.14. The stock’s fifty day moving average is $35.87 and its 200-day moving average is $33.00. Omron has a one year low of $23.23 and a one year high of $43.48.

Omron Company Profile

Omron Corporation (OTCMKTS: OMRNY) is a global leader in automation, sensing, and control technologies. The company designs, manufactures, and sells a wide range of products and solutions for industrial, healthcare and social systems applications. Its core business segments include industrial automation—featuring programmable logic controllers, sensors, relays, servo motors and temperature controllers—and healthcare products such as blood pressure monitors, digital thermometers and nebulizers.

Founded in 1933 by Kazuma Tateishi in Kyoto, Japan, Omron began with the development of the first Japanese automatic timer.